Abstract:BACKGROUND Gastric cardia adenocarcinoma (GCA), which has been classified as type II adenocarcinoma of the esophagogastric junction in western countries, is of similar geographic distribution with esophageal squamous cell carcinoma in China, and even referred as "sister cancer" by Chinese oncologists. The molecular mechanism for GCA is largely unknown. Recent studies have shown that decreased expression of E-cadherin is associated with the invasion and metastasis of multiple cancers. However, the E-cadherin expression has not been well characterized in gastric cardia carcinogenesis and its effect on GCA prognosis. AIM To characterize E-cadherin expression in normal gastric cardia mucosa, dysplasia and GCA tissues, and its influence on prognosis for GCA. METHODS A total of 4561 patients with GCA were enrolled from our previously established GCA and esophageal cancer databases. The enrollment criteria included radical surgery for GCA, but without any radio- or chemo-therapy before operation. The GCA tissue from 4561 patients and matched adjacent normal epithelial tissue (n = 208) and dysplasia lesions (n = 156) were collected, and processed as tissue microarray for immunohistochemistry. The clinicopathological characteristics were retrieved from the medical records in hospital and follow-up was carried out through letter, telephone or home interview. E-cadherin protein expression was determined by two step immunohistochemistry. Kaplan-Meier and Cox regression analyses were used to correlate E-cadherin protein expression with survival of GCA patients RESULTS Of the 4561 GCA patients, there were 3607 males with a mean age of 61.6 8.8 and 954 females with a mean age of 61.9 +/- 8.6 years, respectively. With the lesions progressed from normal gastric cardia mucosa to dysplasia and GCA, the positive immunostaining rates for E-cadherin decreased significantly from 100% to 93.0% and 84.1%, respectively (R-2 = 0.9948). Furthermore, E-cadherin positive immunostaining rate was significantly higher in patients at early stage (0 and I) than in those at late stage (II and III) (92.7% vs 83.7%, P = 0.001). E-cadherin positive expression rate was significantly associated with degree of differentiation (P = 0.001) and invasion depth (P < 0.001). Multivariate analysis showed that the GCA patients with positive E-cadherin immunostaining had better survival than those with negative (P = 0.026). It was noteworthy that E-cadherin positive expression rate was similar in patients with positive and negative lymph node metastasis. However, in patients with negative lymph node metastasis, those with positive expression of E-cadherin had better survival than those with negative expression (P = 0.036). Similarly, in patients with late stage GCA, those with positive expression of E-cadherin had better survival than those with negative expression (P = 0.011). CONCLUSION E-cadherin expression may be involved in gastric cardia carcinogenesis and low expression of E-cadherin may be a promising early biomarker and overall survival predictor for GCA.

Expressions of SIRT 1, E-cadherin and MLH 1 in Gastric Cardia Carcinoma and Their Relationship

Study on the Clinicopathologic Significance and Expression of SIRT1

Expression Of Sirt1 In Gastric Cardiac Cancer And Its Clinicopathologic Significance

Expressions of SIRT1 As Prognostic Biomarker on Resectable Gastric Cancer Patient

Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1.

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

The Significance of TDGF-1 Expression in Gastric Cancer and Its Role in Epithelial-mesenchymal Transition

Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer.

[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]

Clinicopathological Significance of SIRT1 Expression in Colorectal Adenocarcinoma

Characterization of E-cadherin Expression in Normal Mucosa, Dysplasia and Adenocarcinoma of Gastric Cardia and Its Influence on Prognosis

Mir-301a-5p/Scin Promotes Gastric Cancer Progression Via Regulating Stat3 And Nf-Kappa B Signaling

Overexpression of Sirtuin-1 is Associated with Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma

High Levels of SIRT1 Expression Enhance Tumorigenesis and Associate with a Poor Prognosis of Colorectal Carcinoma Patients

Study on the Different Expression of Molecular Markers Between Cardiac Cancer and Distal Gastric Cancer and Their Correlations with Clinicopathological Features

The Clinical Significance of Tumor Angiogenesis and Invasiveness-Related Gene Expressions in Gastric Cancer

Overexpression of Endothelial Cell Specific Molecule-1 (ESM-1) in Gastric Cancer

Expression and clinical significance of VEGF and markers of EMT in gastric cancer

Overexpression and Clinicopathological Significance of NET-1,Ki67 and CD34 in Gastric Carcinoma

[Differential Expression of Immunohistochemical Markers Between Cardiac Carcinoma and Carcinoma in Antrum of Stomach and Correlation Thereof with Clinicopathological Factors].